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occurred for 19 years. From 1959 to
1983, numerous TBEV foci existed in
northeastern Germany (3). From 1960
to 1985, a total of 4 human cases were
seen 10 km east of Neustrelitz. From
1983 to 1989, numerous attempts to
cultivate TBEV from ticks or small
mammals failed (3). In 1992, TBEV
genome was detected by PCR in 3 tick
pools from the island of Usedom, and
in 2 pools from the Darss peninsula,
100 km northeast of Neustrelitz. From
1993 to July 2004, TBEV genome
was not detected in 16,098 ticks col-
lected from 275 regions of northeast-
ern Germany, including the county
where Lake Woblitz is situated, as
part of a statewide surveillance pro-
gram (State Health Services, unpub.
data). However, during 2004, this
county reported 24 cases of Lyme dis-
ease (2003: 10 cases; 2002: 8 cases;
2001: 1 case). Therefore, our tick-
borne encephalitis case might repre-
sent intensified amplification cycles
of tickborne infectious agents in 2004. 
The absence of tickborne
encephalitis cases for 20 years does
not likely represent a lack of data
before or a lack of interest after the
reunification of Germany. Tickborne
encephalitis was a reportable disease
under East German regulations, and
tickborne encephalitis surveillance
was intensified after reunification (3). 
Eight weeks after our patient’s tick
bite, 160 Ixodes ricinus ticks were
collected from 10 pools near Lake
Woblitz. RNAwas isolated in 5 mol/L
guanidium isothiocyanate solution,
extracted by phenolchloroform, and
precipitated with ethanol. cDNA was
amplified by nested reverse transcrip-
tion–PCR and detected by elec-
trophoresis (6). In 2 of these pools,
PCR directed towards the 5′ terminal
noncoding region of the TBEV
genome yielded a 104-bp fragment,
but the sequence was not specific for
flaviviruses. 
This case does not prove a north-
bound spread of tickborne encephali-
tis in northeastern Germany. Rather, it
shows that after years of negative
tickborne encephalitis test results in
ticks, old tickborne encephalitis foci
may retain activity. Thus, tickborne
encephalitis should be included in the
differential diagnosis of meningoen-
cephalitis in northeastern Germany,
even if the patient has not been in
tickborne encephalitis–endemic areas.
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Social Impact of
Leishmaniasis,
Afghanistan
To the Editor: For almost a
decade, Kabul, Afghanistan, has had
the highest incidence of cutaneous
leishmaniasis in the world, with an
estimated 67,500 to 200,000 cases
each year (1–3). Because of sandfly
vector exposure, most leishmaniasis
lesions occur on the face; anecdotal
reports of severe stigma are associat-
ed with the disease (3). To prioritize
aspects of operational activities and
before developing a disease-specific
health education strategy, we collect-
ed data on knowledge, attitudes, and
perceptions regarding leishmaniasis.
In October 2002, we randomly
chose 5 of Kabul’s 14 administrative
districts to carry out a house-to-house
survey (HHS) as well as 13 focus
group discussions (FGDs) with
women. The 5 districts chosen were
Karti-Seh (HHS) and Dasht-e-Barchi
(4 FGDs), Karti-Now (3 FGDs),
Arzam Qemat (3 FGDs), and Rahman
Mena (3 FGDs). The survey was con-
ducted by using a standardized, multi-
ple-choice questionnaire. The most
senior, available family member in
252 neighboring households was
interviewed, after the first household
was randomly selected (2). We
focused on women in FGDs because
they have greater risk for leishmania-
sis than men (2,3) and are often the
primary caregivers in Afghan culture
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(4). The same HHS questions were
used in the FGDs. Surveyors random-
ly chose a house in each district and
explained the study’s purpose to resi-
dents. When residents agreed to host
an FGD, women from neighboring
households were invited to join.
FGDs had a maximum of 12 partici-
pants and lasted 2 hours; answers to
questions were recorded on paper.
FGD moderators were instructed to
pose questions, encourage free discus-
sion, and ask participants to empha-
size personal experiences. FGD data
were analyzed by thematic analysis of
the transcripts. Surveys were carried
out by experienced surveyors, who
have been involved in previous leish-
maniasis prevalence surveys or inter-
vention trials (2–4). Written approval
for the study was obtained from the
Afghan Ministry of Health, and oral
consent was given by all surveyed
persons. Active case-patients sur-
veyed were offered free antileishma-
nial treatment at the HealthNet
International leishmaniasis clinics.
A total of 252 and 108 persons
were surveyed in the HHS and FGDs,
respectively, although not all respon-
dents answered every question. Our
study confirmed the prevalence of
cutaneous leishmaniasis in Kabul; 128
(51%) of 252 HHS respondents report-
ed a family member with leishmania-
sis. Respondents were knowledgeable
about leishmaniasis: of 360 total HHS
and FGD respondents, 287 (80%) said
that it was a disease, and 160 (44%)
said that it was acne. Of 66 FGD
respondents who knew that leishmani-
asis was a disease, 29 (44%) knew that
it was transmitted by mosquitoes. Of
104 FGD respondents, 41 (43%) could
describe the clinical symptoms of
leishmaniasis (each was asked to give
1 answer only), i.e., an open wound (n
= 17) that is not painful (n = 7) and
takes a long time to cure (n = 17).
The principal finding of our study
is that we show, for the first time, the
extent of the disease’s social impact in
Kabul. Because erroneous beliefs
exist that the disease can be transmit-
ted by person-to-person physical con-
tact (of 360 respondents, the most
common answers were “touching” [n
= 86] and “sharing meals and house-
hold goods” [n = 26]), affected people
are excluded from communal life.
This exclusion can consist of minor
domestic restrictions (40 [46%] of 89
FGD respondents said they would not
share plates, cups, or towels with
leishmaniasis patients) or more severe
measures that lead to physical and
emotional isolation. FGDs showed
that leishmaniasis caused trauma; of
83 respondents who had children with
leishmaniasis, 45 (54%) said their
children felt disfigured because of
lesions or scars (n = 20), because of
painful treatment (intralesional or
intramuscular injections with pen-
tavalent antimony, n = 19), or because
they were excluded from play with
other children (n = 6). Of 96 FGD
respondents, 21 (22%) said that a
mother with leishmaniasis should not
breast-feed her child; 48 (51%) of 94
FGD respondents would prevent
someone with leishmaniasis from
touching or hugging their children; 55
(57%) of 96 respondents said that a
person with leishmaniasis should not
be allowed to cook for the family; and
21 (22%) of 94 respondents said that a
woman with a leishmaniasis lesion or
scar will have difficulty finding a hus-
band. Severity and visibility of the
lesions as well as past experience of
leishmaniasis within the family influ-
enced respondents’ answers.
The study yielded 2 other impor-
tant findings. First, 245 (97%) of 252
HHS respondents knew that leishma-
niasis does not resolve without treat-
ment and that patients should seek
professional assistance. Of 344 HHS
and FGD respondents, 322 (94%) said
that leishmaniasis patients should
seek a doctor or clinic for treatment
(as opposed to a traditional healer or
self-medication). Second, 205 (57%)
of 358 HHS and FGD respondents use
methods to prevent exposure to sand-
fly vectors, i.e., screens for windows
and doors (n = 108), nets around beds
(n = 63), indoor insecticide spraying
(n = 24), or other method of personal
protection (n = 10); 152 (78%) of 252
HHS respondents said that they did
not have a net over their bed because
it was too expensive.
Kabul residents are knowledgeable
about leishmaniasis; they are able to
describe its symptoms and the neces-
sity for professional treatment.
However, we show that while many
FGD respondents knew that leishma-
niasis is transmitted by “mosquitoes,”
severe stigma and trauma are associ-
ated with the disease, particularly in
children and women. Our operational
experience corroborates this finding,
which underlines the disease’s social
effect on the local population and
refuting the belief that leishmaniasis
is of little health importance (5). Half
of the 15,983 leishmaniasis patients
treated at HNI clinics in 2003 were
women. Although women are at
greater risk for leishmaniasis, they do
not typically attend healthcare pro-
grams in Afghanistan because of soci-
ocultural constraints (e.g., husbands
not allowing their wife or daughters to
attend) (6). In addition to diagnosing
and treating active cases, HealthNet
International will now focus on leish-
maniasis education activities in
Kabul, outlining aspects of disease
transmission and prevention, as well
as disseminating messages to reduce
the disease’s social impact.
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Methicillin-resistant
Staphylococcus
aureus Toxic Shock
Syndrome
To the Editor: Toxic shock syn-
drome (TSS), which can be life threat-
ening, is defined by clinical and labo-
ratory evidence of fever, rash, desqua-
mation, hypotension, and multiple
organ failure caused by Staphylococ-
cus aureus toxins. TSS caused
by methicillin-resistant S. aureus
(MRSA) strains has been found
extensively in Japan (1), rarely in the
United States (2), and, thus far, not in
Europe.
We report a case of TSS due to an
MRSA strain that produced a TSS
toxin 1 (TSST-1). A 54-year-old
woman was admitted to the emer-
gency ward of Brugmann University
Hospital, Brussels, with a 2-day histo-
ry of myalgia, diarrhea, and vomiting.
She had undergone surgery for a
palate neoplasia 2 months earlier, and
again 2 weeks earlier, in another hos-
pital. After the second operation, she
had been treated for a local scar infec-
tion with amoxicillin–clavulanic acid
for 1 week.
On physical examination, the
patient was conscious, tachypneic,
pale, and sweating. Her temperature
was 38.2°C and her blood pressure
was 70/50 mm Hg. Abdominal exami-
nation findings were normal. The cuta-
neous operative wound was red and
swollen. Laboratory results included
the following: leukocyte count
19,830/mm³ with 97% polynuclear
neutrophils, platelets 90,000/mm³, cre-
atinine 2.1 mg/dL, bicarbonate 13
mEq/L, cyclic AMP receptor protein
43.7 ng/mL, creatine kinase 514 U/L.
Cultures of blood, stool, and urine
samples were negative for microbial
agents. Puncture of the wound
released 12 mL of pus; culture of the
pus sample yielded an MRSA strain
harboring a TSST-1 gene, detected by
multiplex polymerase chain reaction
as previously described (3).
By molecular typing, the strain
belonged to the epidemic MRSA
pulsed-field gel electrophoresis clone
G10 and carried the staphylococcal
chromosome cassette mec (SCCmec)
type II. This clone belongs to the
sequence type (ST) 5-SCCmec II
clone, formerly named “New-
York/Japan clone,” which has been
associated with neonatal TSS–like
exanthematous disease in Japanese
hospitals (4–6). This epidemic clone,
which is widely disseminated in the
United States, Japan, and Europe, has
been found in 12% of Belgian hospi-
tals during a national survey conduct-
ed in 2001 (6).
The treatment included aggressive
intravenous fluid resuscitation,
administration of dopamine, and
antimicrobial agent therapy with
teicoplamin and clindamycin. The
treatment outcome was favorable. On
the second day, a diffuse cutaneous
macular rash appeared. The acute
renal failure and the biological abnor-
malities resolved. On the fifth day, the
patient was transferred back to the
hospital where she had undergone sur-
gery; extensive peeling then devel-
oped on both of the patient’s hands. 
Our patient met the criteria of TSS:
she had fever, rash, desquamation,
hypotension, vomiting, diarrhea,
myalgias, elevated creatine kinase,
acute renal failure, and thrombocy-
topenia. The diagnosis of staphylo-
coccal TSS was confirmed by bacteri-
ologic results.
Although TSST-1 production by
MRSA strains has been described in
Europe (7), this case is the first of TSS
due to TSST-1–producing MRSA in
Europe. Recently Nathalie van der
Mee-Marquet et al. (8) described the
first case of neonatal TSS–like exan-
thematous disease due to a MRSA
strain containing the TSST-1 gene in
Europe. They emphasized the risk of
emergence of neonatal toxic shock
syndrome–like exanthematous dis-
ease outside Japan.
We would also like to emphasize
the rising risk of TSS due to virulent
MRSA strains outside Japan and par-
ticularly in Europe. The usual recom-
mendations for the treatment of
staphylococcal TSS do not consider
this possibility and consist of a β-lac-
tamase–resistant anti-staphylococcal
agent and clindamycin in some cases
(to decrease the synthesis of TSST-1)
(9–11).
We immediately treated our patient
with teicoplanin and clindamycin
because we suspected a nosocomial
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